Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Techne (TECH) Equity Income (2023 - 2026)

Bio-Techne has reported Equity Income over the past 3 years, most recently at $110000.0 for Q4 2025.

  • For Q4 2025, Equity Income rose 139.13% year-over-year to $110000.0; the TTM value through Dec 2025 reached $922000.0, up 141.57%, while the annual FY2025 figure was $938000.0, 113.71% up from the prior year.
  • Equity Income for Q4 2025 was $110000.0 at Bio-Techne, down from $294000.0 in the prior quarter.
  • Over five years, Equity Income peaked at $1.1 million in Q2 2025 and troughed at -$2.3 million in Q3 2023.
  • A 3-year average of -$550000.0 and a median of -$271500.0 in 2024 define the central range for Equity Income.
  • On a YoY basis, Equity Income climbed as much as 224.24% in 2025 and fell as far as 21.39% in 2025.
  • Year by year, Equity Income stood at -$1.9 million in 2023, then skyrocketed by 102.4% to $46000.0 in 2024, then surged by 139.13% to $110000.0 in 2025.
  • Business Quant data shows Equity Income for TECH at $110000.0 in Q4 2025, $294000.0 in Q3 2025, and $1.1 million in Q2 2025.